Achieve Life Sciences, Inc.
http://achievelifesciences.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Achieve Life Sciences, Inc.
Arthrosurface Markets First Allograft Implant To Replace Arthritic Thumb Bone
Orthopedic implant company Arthrosurface is hoping to get hand surgeons' attention with its new allograft thumb implant to treat osteoarthritis.
Boehringer Adds Yuhan’s First-In-Class Dual Agonist To NASH Portfolio
Yuhan reaches $870m NASH licensing-out deal with Boehringer, touting its competitiveness in the space after earlier alliance with Gilead. The collaboration for first-in-class GLP-1/FGF21 dual agonist is poised to beef up German firm's R&D expertise in cardiometabolic disease.
Deal Watch: Vertex Expands Gene-Editing Efforts With A Pair Of Deals
CF-focused Vertex will buy Exonics and expand a collaboration with CRISPR Therapeutics, with plans to develop therapies for DMD and myotonic dystrophy type 1. Merck acquires TGFβ-focused Tilos, while Achaogen offloads most of its assets at auction.
BI Inks Second Obesity Pact With Denmark’s Gubra
The German group has signed a second deal with Gubra to develop poly-agonist peptides for obesity that could be worth up to €240m.
Company Information
- Industry
-
Pharmaceuticals
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- OncoGenex Pharmaceuticals, Inc.
- Sonus Pharmaceuticals, Inc.